Cargando…
In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects
BACKGROUND: Abnormalities of pre-mRNA splicing are increasingly recognized as an important mechanism through which gene mutations cause disease. However, apart from the mutations in the donor and acceptor sites, the effects on splicing of other sequence variations are difficult to predict. Loosely d...
Autores principales: | Lastella, Patrizia, Surdo, Nicoletta Concetta, Resta, Nicoletta, Guanti, Ginevra, Stella, Alessandro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1590028/ https://www.ncbi.nlm.nih.gov/pubmed/16995940 http://dx.doi.org/10.1186/1471-2164-7-243 |
Ejemplares similares
-
Missense mutations of MLH1 and MSH2 genes detected in patients with gastrointestinal cancer are associated with exonic splicing enhancers and silencers
por: ZHU, MING, et al.
Publicado: (2013) -
MSH2 and MLH1 testing
por: Kurzawski, Grzegorz, et al.
Publicado: (2008) -
No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study
por: Dominguez-Valentin, Mev, et al.
Publicado: (2021) -
Clinical presentation and genetic analyses of neurofibromatosis type 1 in independent patients with monoallelic double de novo closely spaced mutations in the NF1 gene
por: Stella, Alessandro, et al.
Publicado: (2022) -
Alpha-melanocyte stimulating hormone (α-MSH): biology, clinical relevance and implication in melanoma
por: Dall’Olmo, Luigi, et al.
Publicado: (2023)